drugset / Trial / NCT00003075

Fenretinide in Treating Patients With Cervical Neoplasia

NCT00003075

RandomizedSingle-groupTriple-blindPrevention

Summary

RATIONALE: Chemoprevention uses drugs to try and prevent development of cancer. Fenretinide may be effective in treating cervical neoplasia and preventing cervical cancer. PURPOSE: Randomized double-blinded phase III trial to compare the effectiveness of fenretinide to placebo in treating patients with cervical neoplasia.

Timeline

Start
1993-03-05
Primary completion
2001-05-01
Completion
2001-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject fenretinide Small molecule Oral